DALLAS, March 4, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company Sequenom Inc. (Nasdaq:SQNM). The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.
It is available at: http://www.beaconequity.com/i/SQNM
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
Sequenom Inc. is a life sciences company that develops innovative products and diagnostic tests, serving researchers and molecular diagnostics markets. The Company markets the MassARRAY system, a nucleic acid analysis platform that measures genetic material and variations to translate genomic results for the biomedical research environment.
In the report, the analyst notes:
"Many analysts expect growth in the clinical diagnostic market to continue due to favorable long-term trends in genomics and emerging patient-specific diagnostic technologies promised to reduce costs and provide enhanced tools for medical providers. Cancer and infectious diseases (including HIV, HCV and HPV) markets presently lead in this evolving trend.
"The Company suffered a drop in its stock last year following revelations that the Company mishandled some research data, leading to the resignation of the CEO and the executive in charge of research and development, as well as four other employees involved in the matter. On January 15, the Company agreed to settle a class action suit as a result of the mishandling of its test data for Down syndrome, paying $14 million plus stock to close the suit.
"The stock has since bounced back, recently being supported by favorable ratings hikes from a couple of influential analysts, including Pamela Bassett of Cantor Fitzgerald, who raised her rating of the Company to a 'Buy' from a 'Hold' and lifted her price target to $16 from $4."
To read the entire report visit: http://www.beaconequity.com/i/SQNM
See what investors are saying about these stocks at: penny stock forum
BeaconEquity.com is one of the industry's largest small-cap report providers striving to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.